Kristiaan Wouters

Associate professor

Dr Kristiaan Wouters has studied Biomedical Sciences at Hasselt University (Belgium). In 2003, he started his PhD research at the Dept. of Molecular Genetics at Maastricht University on the role of macrophages and inflammation in nonalcoholic fatty liver disease. After obtaining his PhD in 2008, he worked as a post-doc in the laboratory of Prof. Bart Staels at the Pasteur Institute in Lille, France, on the role of macrophage polarisation in obesity, diabetes, and atherosclerosis. Kristiaan has returned to Maastricht at the Dept. of Internal Medicine as tenure track researcher setting up his research group 'Translational Immunometabolism'. Since 2019, he has been appointed as Associate Professor.

The group focusses on the immunological events in adipose tissue during obesity and the impact of these events on cardiometabolic complications, such as type 2 diabetes, cardiovascular disease and nonalcoholic fatty liver disease, with a specific focus on the interplay between metabolism and inflammation in innate immune cells.

Current projects focus on the role of reactive dicarbonyls formed during glycolysis on immune cell function in cardiometabolic diseases, and on multivariate analysis of flow cytometry data.



Department of Internal Medicine
Universiteitssingel 50, 6229 ER Maastricht
PO Box 616, 6200 MD Maastricht
Room number: H5.310
T: +31(0)43 388 42 33

  • 2023
    • Zhang, X. D., Scheijen, J. L. J. M., Stehouwer, C. D. A., Wouters, K., & Schalkwijk, C. G. (2023). Increased methylglyoxal formation in plasma and tissues during a glucose tolerance test is derived from exogenous glucose. Clinical Science, 137(8), 697-706.
    • Hanssen, N. M. J., Tikellis, C., Pickering, R. J., Dragoljevic, D., Lee, M. K. S., Block, T., Scheijen, J. L. J. M., Wouters, K., Miyata, T., Cooper, M. E., Murphy, A. J., Thomas, M. C., & Schalkwijk, C. G. (2023). Pyridoxamine prevents increased atherosclerosis by intermittent methylglyoxal spikes in the aortic arches of ApoE-/- mice. Biomedicine & Pharmacotherapy, 158, [114211].
    • Schalkwijk, C. G., Micali, L. R., & Wouters, K. (2023). Advanced glycation endproducts in diabetes-related macrovascular complications: focus on methylglyoxal. Trends in Endocrinology and Metabolism, 34(1), 49-60.
  • 2022
    • De Hert, E., Verboven, K., Wouters, K., Jocken, J. W. E., & De Meester, I. (2022). Prolyl Carboxypeptidase Activity Is Present in Human Adipose Tissue and Is Elevated in Serum of Obese Men with Type 2 Diabetes. International journal of molecular sciences, 23(21), [13529].
    • Goossens, P., Lu, C., Cao, J., Gijbels, M. J., Karel, J. M. H., Wijnands, E., Claes, B. S. R., Fazzi, G. E., Hendriks, T. F. E., Wouters, K., Smirnov, E., van Zandvoort, M. J. M., Balluff, B., Cuypers, E., Donners, M. M. P. C., Heeren, R. M. A., & Biessen, E. A. L. (2022). Integrating multiplex immunofluorescent and mass spectrometry imaging to map myeloid heterogeneity in its metabolic and cellular context. Cell Metabolism, 34(8), 1214-1225.e6.
    • Zhang, X., Schalkwijk, C. G., & Wouters, K. (2022). Immunometabolism and the modulation of immune responses and host defense: A role for methylglyoxal?Biochimica et Biophysica Acta-Molecular Basis of Disease, 1868(8), [166425].
    • Ottaviani, L., Pinto, V. S., Knoops, K., Wouters, K., Martins, P. A. D., & Abreu, R. (2022). Cre/Lox-Assisted Tracking Of Cardiac Intercellular Communication. Tissue Engineering, 28, S339-S340.
  • 2021
    • Tinnevelt, G. H., Wouters, K., Postma, G. J., Folcarelli, R., & Jansen, J. J. (2021). High-throughput single cell data analysis - A tutorial. Analytica Chimica Acta, 1185, [338872].
    • Bogie, J. F. J., Vanmierlo, T., Vanmol, J., Timmermans, S., Mailleux, J., Nelissen, K., Wijnands, E., Wouters, K., Stinissen, P., Gustafsson, J. A., Steffensen, K. R., Mulder, M., Zelcer, N., & Hendriks, J. J. A. (2021). Liver X receptor beta deficiency attenuates autoimmune-associated neuroinflammation in a T cell-dependent manner. Journal of Autoimmunity, 124, [102723].
    • van Dongen, K. C. W., Linkens, A. M. A., Wetzels, S. M. W., Wouters, K., Vanmierlo, T., van de Waarenburg, M. P. H., Scheijen, J. L. J. M., de Vos, W. M., Belzer, C., & Schalkwijk, C. G. (2021). Dietary advanced glycation endproducts (AGEs) increase their concentration in plasma and tissues, result in inflammation and modulate gut microbial composition in mice; evidence for reversibility. Food Research International, 147, [110547].